Literature DB >> 29443327

The AAN's role in the development of health insurer coverage policy.

Saty Satya-Murti1, Katie M Shepard1.   

Abstract

Scientific, evidence-based clinical practice guidelines (CPGs) differ from coverage/policy statements. The latter incorporate values and priorities and translate evidence into human benefit. They assist provider and payer decisions, and abide by extant laws and regulations. Payers have set internal processes for balancing and integrating the intent of CPGs into their coverage/payment policies. Recently, however, their efforts to reach out to respected medical specialty societies for input are increasing. In response, the American Academy of Neurology (AAN) has taken the following steps: 1) it is reacting to, and providing input to, payer requests for policy reviews; 2) it is taking a proactive approach by developing AAN guideline companion documents that describe potential provider impacts and policy implications; and 3) it is commencing an initiative to write its own template policies. This new involvement has met with initial positive outcomes. The AAN will continue to expand efforts to fulfill a growing need in this area.

Entities:  

Year:  2012        PMID: 29443327      PMCID: PMC5798209          DOI: 10.1212/CPJ.0b013e31825a722b

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  15 in total

1.  Evidence-based coverage policy.

Authors:  A M Garber
Journal:  Health Aff (Millwood)       Date:  2001 Sep-Oct       Impact factor: 6.301

2.  Has guideline development gone astray? Yes.

Authors:  R Grol
Journal:  BMJ       Date:  2010-01-29

3.  Science, politics, and values: the politicization of professional practice guidelines.

Authors:  John D Kraemer; Lawrence O Gostin
Journal:  JAMA       Date:  2009-02-11       Impact factor: 56.272

Review 4.  Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

Authors:  Richard M Dubinsky; Janis Miyasaki
Journal:  Neurology       Date:  2009-12-30       Impact factor: 9.910

Review 5.  Transcutaneous electrical nerve stimulation (TENS) versus placebo for chronic low-back pain.

Authors:  Amole Khadilkar; Daniel Oluwafemi Odebiyi; Lucie Brosseau; George A Wells
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

6.  GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.

Authors:  Gordon H Guyatt; Andrew D Oxman; Gunn E Vist; Regina Kunz; Yngve Falck-Ytter; Pablo Alonso-Coello; Holger J Schünemann
Journal:  BMJ       Date:  2008-04-26

7.  Comparing the USPSTF and GRADE approaches to recommendations.

Authors:  Gordon H Guyatt; Mark Helfand; Regina Kunz
Journal:  Ann Intern Med       Date:  2009-09-01       Impact factor: 25.391

8.  Limitations of guidelines for low back pain therapy.

Authors:  Andrea D Furlan; Vicki Pennick
Journal:  Nat Rev Rheumatol       Date:  2009-09       Impact factor: 20.543

9.  Implementing evidence-based health policy in Washington State.

Authors:  Gary M Franklin; Brian R Budenholzer
Journal:  N Engl J Med       Date:  2009-10-29       Impact factor: 91.245

10.  Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone.

Authors:  John Newsom-Davis; Gary Cutter; Gil I Wolfe; Henry J Kaminski; Alfred Jaretzki; Greg Minisman; Inmaculada Aban; Robin Conwit
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.